1.0 Contact Hour(s)
Expires: November 11, 2020
This activity is designed to meet the educational needs of hematologists, hematologists/oncologists, community oncologists, oncology nurses and NPs, pharmacists and other healthcare professionals involved in the treatment of patients with Multiple Myeloma.
After completing this program, participants should be able to:
- Outline recommendations for the diagnosis and risk stratification of patients with multiple myeloma and how this classification impacts treatment decisions throughout the disease continuum
- Evaluate the changing therapeutic landscape for multiple myeloma including an understanding of finalized and ongoing clinical trials, emerging treatment options, and emerging real-world data on the use of novel targeted therapies
- Implement the latest best-practice treatment strategies for optimizing care of patients with multiple myeloma, taking into consideration recent changes in clinical practice guidelines, evolving treatment paradigms, and expert recommendations
This educational activity is designed to provide the hematology/oncology care team with the latest developments and critical insights into the management of Multiple Myeloma. This education will support the healthcare professional in his/her practice setting with the essential tools to critically evaluate efficacy, safety, clinical effectiveness and application.
Statement of Educational Need
Taking into consideration the continued evolution of therapeutic modalities and management strategies for Multiple Myeloma along with the information burden placed on busy healthcare professionals, expert guidance and interpretation of the clinical significance of emerging clinical data will benefit those caring for patients with Multiple Myeloma, allowing for ease of assessment and incorporation into clinical practice.
Mass General Hospital
Mount Sinai Hospital
New York, NY
Cedar Sinai Hospital
Los Angeles, CA